Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening lung diseases with high mortality rates, predominantly attributable to acute and severe pulmonary inflammation. Lomerizine (LMZ) is a calcium channel blocker previously used in preventing and treating migrain...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1236469/full |
_version_ | 1797737404074819584 |
---|---|
author | Yunduan Song Yunduan Song Yusen Gou Jiameng Gao Dongxin Chen Haibo Zhang Wenjuan Zhao Feng Qian Ajing Xu Yao Shen |
author_facet | Yunduan Song Yunduan Song Yusen Gou Jiameng Gao Dongxin Chen Haibo Zhang Wenjuan Zhao Feng Qian Ajing Xu Yao Shen |
author_sort | Yunduan Song |
collection | DOAJ |
description | Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening lung diseases with high mortality rates, predominantly attributable to acute and severe pulmonary inflammation. Lomerizine (LMZ) is a calcium channel blocker previously used in preventing and treating migraine. Here, we found that LMZ inhibited inflammatory responses and lung pathological injury by reducing pulmonary edema, neutrophil infiltration and pro-inflammatory cytokine production in lipopolysaccharide (LPS)-induced ALI mice. In vitro experiments, upon treating with LMZ, the expression of interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α was attenuated in macrophages. The phosphorylation of p38 MAPK, ERK1/2, JNK, and NF-κB p65 was inhibited after LMZ treatment. Furthermore, LPS-induced Ca2+ influx was reduced by treating with LMZ, which correlated with inhibition of pro-inflammatory cytokine production. And L-type Ca2+ channel agonist Bay K8644 (BK) could restore cytokine generation. In conclusion, our study demonstrated that LMZ alleviates LPS-induced ALI and is a potential agent for treating ALI/ARDS. |
first_indexed | 2024-03-12T13:28:12Z |
format | Article |
id | doaj.art-30fa29fee8514efd979f555683ccabe1 |
institution | Directory Open Access Journal |
issn | 1663-9812 |
language | English |
last_indexed | 2024-03-12T13:28:12Z |
publishDate | 2023-08-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj.art-30fa29fee8514efd979f555683ccabe12023-08-25T01:38:21ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-08-011410.3389/fphar.2023.12364691236469Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influxYunduan Song0Yunduan Song1Yusen Gou2Jiameng Gao3Dongxin Chen4Haibo Zhang5Wenjuan Zhao6Feng Qian7Ajing Xu8Yao Shen9Department of Respiratory and Critical Care Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, ChinaDepartment of Clinical Laboratory, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Respiratory and Critical Care Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, ChinaShanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, ChinaShanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, ChinaShanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, ChinaShanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Clinical Pharmacy, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Respiratory and Critical Care Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, ChinaAcute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening lung diseases with high mortality rates, predominantly attributable to acute and severe pulmonary inflammation. Lomerizine (LMZ) is a calcium channel blocker previously used in preventing and treating migraine. Here, we found that LMZ inhibited inflammatory responses and lung pathological injury by reducing pulmonary edema, neutrophil infiltration and pro-inflammatory cytokine production in lipopolysaccharide (LPS)-induced ALI mice. In vitro experiments, upon treating with LMZ, the expression of interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α was attenuated in macrophages. The phosphorylation of p38 MAPK, ERK1/2, JNK, and NF-κB p65 was inhibited after LMZ treatment. Furthermore, LPS-induced Ca2+ influx was reduced by treating with LMZ, which correlated with inhibition of pro-inflammatory cytokine production. And L-type Ca2+ channel agonist Bay K8644 (BK) could restore cytokine generation. In conclusion, our study demonstrated that LMZ alleviates LPS-induced ALI and is a potential agent for treating ALI/ARDS.https://www.frontiersin.org/articles/10.3389/fphar.2023.1236469/fulllomerizineacute lung injurycalciummacrophagecytokineinflammation |
spellingShingle | Yunduan Song Yunduan Song Yusen Gou Jiameng Gao Dongxin Chen Haibo Zhang Wenjuan Zhao Feng Qian Ajing Xu Yao Shen Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx Frontiers in Pharmacology lomerizine acute lung injury calcium macrophage cytokine inflammation |
title | Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx |
title_full | Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx |
title_fullStr | Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx |
title_full_unstemmed | Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx |
title_short | Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx |
title_sort | lomerizine attenuates lps induced acute lung injury by inhibiting the macrophage activation through reducing ca2 influx |
topic | lomerizine acute lung injury calcium macrophage cytokine inflammation |
url | https://www.frontiersin.org/articles/10.3389/fphar.2023.1236469/full |
work_keys_str_mv | AT yunduansong lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx AT yunduansong lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx AT yusengou lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx AT jiamenggao lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx AT dongxinchen lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx AT haibozhang lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx AT wenjuanzhao lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx AT fengqian lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx AT ajingxu lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx AT yaoshen lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx |